Single-center, single-dose, open-label, laboratory-blinded, randomized, two-treatment, two-period bioequivalence (BE) study comparing the Test Product Apixaban 5 mg film-coated tablets (MEDITOP) with the Reference Product Eliquis 5 mg film-coated tablets (Bristol-Myers Squibb/Pfizer) under fasting conditions.

2025-523137-25-00 Protocol MEDITOP/2025/01 Human pharmacology (Phase I) - Bioequivalence study Ended

Start 3 Nov 2025 · End 25 Nov 2025 · Status Ended · 1 EU/EEA countries · 1 sites · Protocol MEDITOP/2025/01

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Bioequivalence study
Status Ended
Participants planned 36
Countries 1
Sites 1

Comparative bioequivalence study in healthy volunteers under fasting conditions.

Key facts

Sponsor
MEDITOP Gyogyszeripari Kft.
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Cardiovascular Diseases [C14]
Trial duration
3 Nov 2025 → 25 Nov 2025
Decision date (initial)
2025-09-10
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Comparative bioequivalence study in healthy volunteers under fasting conditions.

VersionLevelCodeTermSystem organ class
21.1 PT 10014522 Embolism venous 100000004866

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

MEDITOP Gyogyszeripari Kft.

Sponsor organisation
MEDITOP Gyogyszeripari Kft.
Address
Ady Endre Utca 1
City
Pilisborosjeno
Postcode
2097
Country
Hungary

Scientific contact point

Organisation
MEDITOP Gyogyszeripari Kft.
Contact name
Dr. Mészáros Ágota

Public contact point

Organisation
MEDITOP Gyogyszeripari Kft.
Contact name
Dr. Papp Zsuzsanna

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Czechia Ended 36 1
Rest of world 0

Investigational sites

Czechia

1 site · Ended
Quinta-Analytica s.r.o.
Clinical Unit, Prazska 1486/18c, Hostivar, Prague

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Czechia 2025-11-03 2025-11-25 2025-11-03 2025-11-15

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-08-13 Czechia Acceptable
2025-09-09
2025-09-10